Oscotec Inc Relative Valuation - Oscotec Inc - Alpha Spread
O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 38 050 KRW 12.08% Market Closed
Market Cap: 1.4T KRW
Have any thoughts about
Oscotec Inc?
Write Note

Relative Value

The Relative Value of one Oscotec Inc stock under the Base Case scenario is 6 413.12 KRW. Compared to the current market price of 38 050 KRW, Oscotec Inc is Overvalued by 83%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6 413.12 KRW
Overvaluation 83%
Relative Value
Price
O
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
2
Median 3Y
176.8
Median 5Y
130.4
Industry
2.6
Forward
42.7
vs History
vs Industry
Median 3Y
-39.6
Median 5Y
-47.3
Industry
22.9
Forward
-307.5
vs History
vs Industry
Median 3Y
-42.8
Median 5Y
-42.8
Industry
17.6
vs History
vs Industry
Median 3Y
-41
Median 5Y
-48.5
Industry
25.2
vs History
55
vs Industry
3
Median 3Y
13.7
Median 5Y
14.2
Industry
2.2
vs History
7
vs Industry
2
Median 3Y
158.4
Median 5Y
118
Industry
2.7
Forward
40.2
vs History
9
vs Industry
1
Median 3Y
259.9
Median 5Y
213.2
Industry
5.4
vs History
vs Industry
Median 3Y
-32.4
Median 5Y
-34.5
Industry
13.9
Forward
-286.6
vs History
vs Industry
Median 3Y
-30.5
Median 5Y
-32.3
Industry
17.3
Forward
-215.5
vs History
vs Industry
Median 3Y
-38.7
Median 5Y
-38.7
Industry
16.1
vs History
vs Industry
Median 3Y
-35.4
Median 5Y
-40.1
Industry
18.8
vs History
17
vs Industry
3
Median 3Y
24.5
Median 5Y
24.8
Industry
2

Multiples Across Competitors

Competitors Multiples
Oscotec Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Oscotec Inc
KOSDAQ:039200
1.4T KRW 313.1 -55 -43 -40.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.3 38.2 25.5 29.2
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
CH
Roche Holding AG
SIX:ROG
206.1B CHF 3.5 17.9 10.1 12
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Novartis AG
SIX:NOVN
191.2B CHF 4.6 13.8 10.9 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average P/E: 36.1
Negative Multiple: -55
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.2
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
17.9
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Novartis AG
SIX:NOVN
13.8
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%
EV/EBITDA Multiple
EBITDA Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average EV/EBITDA: 445.1
Negative Multiple: -43
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A
US
Eli Lilly and Co
NYSE:LLY
57.4
191%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
DK
Novo Nordisk A/S
CSE:NOVO B
25.5
86%
US
Johnson & Johnson
NYSE:JNJ
12.4
12%
US
Merck & Co Inc
NYSE:MRK
13.7
342%
CH
Roche Holding AG
SIX:ROG
10.1
21%
UK
A
AstraZeneca PLC
NASDAQ:AZN
17.1
60%
CH
Novartis AG
SIX:NOVN
10.9
9%
US
Pfizer Inc
NYSE:PFE
12.6
30%

See Also

Discover More
Back to Top